Effects of hydrogen sulfide-releasing L-DOPA derivatives on glial activation: potential for treating Parkinson disease. - Wikidata - awgldk - TriplyDB

Effects of hydrogen sulfide-releasing L-DOPA derivatives on glial activation: potential for treating Parkinson disease.

Effects of hydrogen sulfide-releasing L-DOPA derivatives on glial activation: potential for treating Parkinson disease.

http://www.wikidata.org/entity/Q39718802

about

Anti-cancer activity of new designer hydrogen sulfide-donating hybrids Redox control of microglial function: molecular mechanisms and functional significance Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity Therapeutic effect of hydrogen sulfide-releasing L-Dopa derivative ACS84 on 6-OHDA-induced Parkinson's disease rat model A Long-Term and Slow-Releasing Hydrogen Sulfide Donor Protects against Myocardial Ischemia/Reperfusion Injury Differential mechanisms underlying neuroprotection of hydrogen sulfide donors against oxidative stress.Evidence of inflammatory system involvement in Parkinson's disease.Role of Hydrogen Sulfide in Ischemia-Reperfusion Injury.Combined effect of hydrogen sulphide donor and losartan in experimental diabetic nephropathy in rats Hydrogen sulfide is a signaling molecule and a cytoprotectant.Hydrogen sulfide in biochemistry and medicine.A novel hydrogen sulfide-releasing N-methyl-D-aspartate receptor antagonist prevents ischemic neuronal death Sulfhydration mediates neuroprotective actions of parkin Glutathione metabolism and Parkinson's disease.Upregulation of cystathionine-β-synthetase expression contributes to inflammatory pain in rat temporomandibular joint.The therapeutic potential of hydrogen sulfide: separating hype from hope.Therapeutic potential of new hydrogen sulfide-releasing hybrids.Biology and therapeutic potential of hydrogen sulfide and hydrogen sulfide-releasing chimeras Hydrogen sulfide: physiological properties and therapeutic potential in ischaemia.Sodium thiosulfate attenuates glial-mediated neuroinflammation in degenerative neurological diseases.Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson's disease.New sulfurated derivatives of cinnamic acids and rosmaricine as inhibitors of STAT3 and NF-κB transcription factors.NOSH-aspirin (NBS-1120), a novel nitric oxide and hydrogen sulfide releasing hybrid, attenuates neuroinflammation induced by microglial and astrocytic activation: a new candidate for treatment of neurodegenerative disorders.Toward Hydrogen Sulfide Based Therapeutics: Critical Drug Delivery and Developability Issues.H2S Regulates Hypobaric Hypoxia-Induced Early Glio-Vascular Dysfunction and Neuro-Pathophysiological Effects.Effect of chronic L-dopa or melatonin treatments after dopamine deafferentation in rats: dyskinesia, motor performance, and cytological analysis.High toxicity of hydrogen sulfide by the inhibition of mitochondrial respiration.Age-Dependent, Subunit Specific Action of Hydrogen Sulfide on GluN1/2A and GluN1/2B NMDA Receptors.Regulation of emotional memory by hydrogen sulfide: role of GluN2B-containing NMDA receptor in the amygdala.The dichotomous role of H2S in cancer cell biology? Déjà vu all over again.Hydrogen Sulfide Attenuates Tissue Plasminogen Activator-Induced Cerebral Hemorrhage Following Experimental Stroke.Hydrogen sulfide protects blood-brain barrier integrity following cerebral ischemia.Hydrogen sulfide: its production and functions The new HS-releasing compound ACS94 exerts protective effects through the modulation of thiol homoeostasis

P2860

Q26825705-DD17761C-28D8-42FB-BE7B-6C929652A7C8 Q27000279-175436A4-477B-4658-BC69-8CA786247EE1 Q27027973-762737BF-2231-4D53-B45E-06964E11E4CB Q28485947-C0DA375B-16B4-4AEC-BFA5-8F848032725B Q30855744-AD026134-FC05-41C7-8BAB-94FE2A606975 Q33692977-E00BA5EA-28A9-4CD9-A003-547220C41B8C Q33890818-3EC679C7-83DA-414C-B5EC-F544886EFDF8 Q35647095-9267C50F-CD9A-45C3-BAE7-C9187BEC5431 Q35896349-69FE2814-054E-4DA9-B2BC-32134D413C06 Q35929049-E838C969-6629-4E2F-8C87-358DD26AD9E8 Q35929408-5CA530E8-013C-4690-ACBE-C53AC5D1C913 Q36234796-9A956FEC-D78C-4520-B72D-85B571543995 Q36756670-A32B9FDB-EC40-4250-ABC3-4D8BCC4A9D9F Q37078480-E8D65174-B4EA-450D-B36A-24337D1F8840 Q37567297-469CB2FE-0DEA-44D6-B08B-05357C9782D0 Q37872122-3B694393-87CD-4A5C-A80E-8E5490937AD4 Q37960619-E82353C7-89E2-450C-8580-5DE95A8C0D07 Q38056004-AA85E664-2380-42A8-82B3-8C5F3B768AEF Q38236845-C5DB1C27-482D-4CFA-B0FC-8423BA87A0BF Q38306132-D7121A1F-AFB3-4311-9A87-CBEA90348EDE Q38556918-7ABCCB82-47FC-4C14-9EFF-2A97F33AAFF8 Q38696518-9FBA4B2C-BAE9-4C0A-9C89-DF19CC307766 Q39114886-48394AB6-8DD8-4AB6-A230-CD4A0BF86C83 Q39152370-94E63D34-3B70-4EA6-B060-AE88CB44876D Q39745524-74D99D9D-9587-49DC-8A74-3FB201824440 Q42127267-FBBAF2FD-E27D-4B56-9B12-29AA1C9675F2 Q42759036-F06D53E6-8E76-4F57-9EBC-A9449C9FE472 Q47106415-9AEF7AF9-DE28-4B72-AC80-30B985DD44F8 Q47805373-8F9A7361-5030-4B3A-AD2F-72AD4315DCCE Q49346285-E3A17566-C4FB-45B6-8E93-D9209E2BC255 Q50203349-12E70DB3-BA43-4BD6-BACB-07B5E76163B3 Q50224206-B3EAB22B-8419-4143-8B98-D5777C2294DC Q57120170-6B658488-0F15-4520-A9C5-9A997E55DF01 Q58767723-ACE70608-CE18-426F-9372-4C5A793EE4C0

P2860

Effects of hydrogen sulfide-releasing L-DOPA derivatives on glial activation: potential for treating Parkinson disease.

http://www.wikidata.org/entity/Q39718802

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Effects of hydrogen sulfide-re ...... or treating Parkinson disease.

@en

Effects of hydrogen sulfide-re ...... or treating Parkinson disease.

@nl

type

label

Effects of hydrogen sulfide-re ...... or treating Parkinson disease.

@en

Effects of hydrogen sulfide-re ...... or treating Parkinson disease.

@nl

prefLabel

Effects of hydrogen sulfide-re ...... or treating Parkinson disease.

@en

Effects of hydrogen sulfide-re ...... or treating Parkinson disease.

@nl

P1433

Q39718802-7333F97E-D43A-4C41-93D3-53C3EBA856DB

P1476

Q39718802-1897DE81-53D5-404B-BB61-4A6151336814

P2093

Q39718802-24533448-6496-4F95-856E-1D21CD2F6CA6

Q39718802-47CE06E4-5B88-4566-BBC5-852956E20784

Q39718802-49F29364-CE3D-462C-910B-844DC3591671

Q39718802-5E24112E-290E-47C8-8106-F56C3F2AD748

Q39718802-C0BF54DC-9805-460E-B203-A0CF2CBDD8D5

Q39718802-CDDA2040-FBC6-45DE-88C1-34AF737C486E

P2860

Q39718802-0534BC13-4F2A-4321-8905-F13EBF87C025

Q39718802-0F888FDC-5543-4450-8C7C-7DD840BA22C9

Q39718802-11250B15-0A71-434C-9BE8-1B43D03D311A

Q39718802-13C77743-D5B2-46F3-B726-3FDDE490AA13

Q39718802-1890D795-54BF-435C-96FF-902B282D501F

Q39718802-19A4497C-D24D-47B9-8BA2-0EFDD0D3B6D2

Q39718802-209C6171-B554-4A7E-B5FC-E62C0E2B29E8

Q39718802-27689741-BFB7-4715-8263-D49A006681A7

Q39718802-358C6916-FA70-4F5E-9420-7D1AB84E8280

Q39718802-3D6657A9-8BED-4148-AE48-E3A287A9A025

P304

Q39718802-AEE41622-BFDF-4995-A31F-FFD6C35CB0D8

P31

Q39718802-A839996A-4709-42EC-9C84-B3D64582003D

P356

Q39718802-56D4ADED-9C71-42EB-B4F3-FD3541DCDBB0

P407

Q39718802-53FD6928-A5A5-433B-B01B-ABC1D15381A4

P433

Q39718802-A637BD35-C8F5-4A19-BA53-BB15BC61581C

P478

Q39718802-45DDB553-43EE-4C36-B20F-0EB757989A2E

P50

Q39718802-130B590D-BE3C-402B-8AB2-92EB847C11DD

Q39718802-F7E3B860-FB42-465F-A83E-02477CD4909C

P577

Q39718802-09AF5096-6563-4BE7-ACCA-B14D1A9DE7A4

P698

Q39718802-C7C1EF92-3268-4264-92AB-38FC8328B2B4

P921

Q39718802-C624938A-9D59-4C3F-89D3-6E4AB25BA53B

P932

Q39718802-F0D1E97F-7DE1-461A-BF24-30256671BFD0

P356

JBC.M110.115261

P1433

Journal of Biological Chemistry

P1476

Effects of hydrogen sulfide-re ...... for treating Parkinson disease

@en

P2093

Edith McGeer

http://www.w3.org/2001/XMLSchema#string

Moonhee Lee

http://www.w3.org/2001/XMLSchema#string

Patrick L McGeer

http://www.w3.org/2001/XMLSchema#string

Piero Del Soldato

http://www.w3.org/2001/XMLSchema#string

Ranieri Rossi

http://www.w3.org/2001/XMLSchema#string

Valerio Tazzari

http://www.w3.org/2001/XMLSchema#string

P2860

Hydrogen sulfide mediates the vasoactivity of garlic

Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure

Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease

Non-steroidal anti-inflammatory drugs in Parkinson's disease

H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase

Molecular mechanism of the relation of monoamine oxidase B and its inhibitors to Parkinson's disease: possible implications of glial cells

Neuroprotective effects of hydrogen sulfide on Parkinson's disease rat models.

Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.

Neuroprotective and neurotoxic roles of levodopa (L-DOPA) in neurodegenerative disorders relating to Parkinson's disease.

Neuroinflammatory processes in Parkinson's disease.

P304

17318-17328

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M110.115261

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

285

http://www.w3.org/2001/XMLSchema#string

P50

Daniela Giustarini

P577

2010-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20368333

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

2878495

http://www.w3.org/2001/XMLSchema#string